Sonidegib binds to and inhibits a transmembrane protein to disrupt hedgehog pathway signal transduction and leading to antitumor activity in patients with locally advanced basal cell carcinoma.
Lisa Ruohoniemi, PharmD
Advertisement
Articles by Lisa Ruohoniemi, PharmD
Pharmacists can assess patients' needs, evaluate what is required for specific destinations, and provide relevant resources.
Advertisement
Latest Updated Articles
Call the Shots on Travel VaccinesPublished: September 27th 2021 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
2
A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin
3
Oral Semaglutide Shows Promise for Weight Loss and Cardiometabolic Health
4
Low-Dose Aspirin Linked to Lower Cardiovascular Risk in Type 2 Diabetes
5
